The price trend of molotinib/mometinib in 2025 is revealed

Momelotinib is a new oral targeted drug mainly used to treat myeloproliferative diseases, especially primary myelofibrosis (PMF) and other related myeloproliferative tumors. As an interferon and tyrosine kinase inhibitor, it plays an important role in regulating cell signaling and inhibiting tumor cell proliferation. The mechanism of action of molotinib is mainly through inhibiting the JAK (Janus kinase) signaling pathway, which is closely related to the occurrence and development of various hematological diseases.

In clinical trials, molotinib has shown good efficacy and can significantly improve patients' symptoms, including splenomegaly and anemia. It can not only alleviate the pathological manifestations of the disease, but also improve the patient's quality of life. In addition, molotinib has also been found to have some unique effects, such as the potential to combat anemia, which gives it a competitive advantage in the treatment of myeloproliferative diseases. Compared with traditional treatment methods, the targeted treatment characteristics of molotinib enable it to target tumor cells more accurately, thereby reducing damage to normal cells and reducing the occurrence of side effects.

Currently, the original drug of molotinib has not been put on the shelves in the Chinese market, so it cannot be included in the scope of medical insurance. The U.S. version of original drugs marketed overseas usually comes in specifications such as 100mg*30 tablets, 150mg*30 tablets, and 200mg*30 tablets. The price of each box may reach 200,000 yuan (the price will change due to exchange rate fluctuations). Overall, the cost is very high. In addition, the first generic drug of molotinib has been developed and sold. Its ingredients are similar to the original drug. For example, the 100mg*30 tablets produced by Lucius Pharmaceuticals in Laos are priced at about 2,000 yuan (also affected by the exchange rate), which is relatively more economical.

Reference materials:https://en.wikipedia.org/wiki/Momelotinib